AstraZeneca Highlights Will Present First Data From Phase 3 ELEVATE-TN Trial Assessing CALQUENCE In Patients with Previously-Untreated Chronic Lymphocytic Leukemia At ASH Dec. 7-10, 2019
Benzinga Newsdesk